Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
- 1 May 1990
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 87 (10) , 3982-3986
- https://doi.org/10.1073/pnas.87.10.3982
Abstract
The alternative complement pathway is capable of discriminating human cells and tissues from a wide variety of potential pathogens. It has been recently demonstrated that attachment of complement component C3b to activator-derived molecules (e.g., small polysaccharides) restricts inactivation of C3b by factors H and I in a manner similar to activator surfaces. It is now shown that restriction is reversed by certain soluble polyanions (e.g., sialoglycopeptides, heparin, or dextran sulfate) that mimic the effects of sialic acid and glycosaminoglycans on human cells and tissues. Fluid-phase polyanions enhanced binding of factor H to C3b attached to activating particles, indicating that the effect resulted from increased affinity between C3b and factor H. The enhancement was specific for activator-bound C3b since no enhancement was observed on nonactivating particles. While several polyanions could cause this effect, some polyanions could not, indicating specificity. The active polyanions also inhibited lysis of cells via the alternative pathway. The binding site for sialic acid appears to reside on factor H, since factor H bound to heparin-agarose and to sialic acid-bearing fetuin-agarose, whereas C3b bound to neither the under the same conditions. These observations suggest that occupation of a specific site on factor H by polyanions induces an increase in the C3b-H affinity, resulting in discrimination of host cells and tissues from alternative pathway-activating foreign cells.Keywords
This publication has 46 references indexed in Scilit:
- MOLECULAR ORGANIZATION AND FUNCTION OF THE COMPLEMENT SYSTEMAnnual Review of Biochemistry, 1988
- Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragmentsMolecular Immunology, 1987
- The alternative pathway of complementSpringer Seminars in Immunopathology, 1984
- Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3bMolecular Immunology, 1983
- Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and IBiochemistry, 1983
- Restriction of alternative complement pathway activation by sialosylglycolipidsNature, 1982
- Identification of a major human serum DNA-binding protein as β1H of the alternative pathway of complement activationBiochemical and Biophysical Research Communications, 1980
- Activation of the alternative pathway of complement: Inhibition by low molecular weight polyanionsImmunochemistry, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- The Properdin System and Immunity: I. Demonstration and Isolation of a New Serum Protein, Properdin, and Its Role in Immune PhenomenaScience, 1954